The essentials
FDA approves Moderna and Pfizer COVID-19 vaccines targeting XFG strain with eligibility criteria.
The FDA has approved updated COVID-19 vaccines designed to target the XFG strain, marking a continued effort to address evolving variants. Both Moderna and Pfizer received approval for their respective vaccines, with each manufacturer establishing specific eligibility criteria for recipients.
The updated formulations represent regulatory action taken in response to circulating variants. Eligibility requirements differ between the two approved vaccines, with each manufacturer outlining who qualifies for vaccination under their approval.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
Regulatory Milestones: Updated Vaccines Clear FDA Review Process
Both Moderna and Pfizer secured FDA approval for their updated COVID-19 vaccines, demonstrating the regulatory pathway for variant-specific formulations. The approvals establish distinct eligibility frameworks for each manufacturer's vaccine, requiring recipients to meet specified criteria before administration.
Vaccine Rollout Expands Protection Against Evolving COVID-19 Variants
Updated vaccines targeting the XFG strain are now available through FDA-approved manufacturers Moderna and Pfizer. Each vaccine implements eligibility requirements to guide appropriate distribution. The approvals expand vaccination options as the pandemic continues to evolve.